What is the mechanism of action of bimekizumab and how does it differ from other systemic psoriasis treatments?
Featuring Mark Lebwohl, MD | Senior Clinical Advisor |
Professor and Chairman Emeritus of the Kimberly and Eric J. Waldman Department of Dermatology
Dean for Clinical Therapeutics at the Icahn School of Medicine, Mount Sinai
New York, NY
Related CME
Related Media
Powered by Polaris TM